Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf261 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Lillian Tugume und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Sciences, Infectious Diseases Institute, Makerere University, Kampala Uganda. Hauptthemen laut MEDLINE: Tuberculosis, Meningeal, C-Reactive Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Northern Pacific Global Health, Wellcome Trust.
Abstract (Originalsprache)
We enrolled 135 adults with tuberculous meningitis (TBM), including 83% with HIV. Participants with baseline C-reactive protein (CRP) ≥40 mg/L had 3 times higher odds of an 8-week modified Rankin scale ≥4 (adjusted odds ratio, 2.78; 95% CI: 1.28–6.04; P = .010). CRP is a viable prognostic biomarker in TBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Health Sciences, Infectious Diseases Institute, Makerere University, Kampala Uganda.
- Department of HIV Interventions, MRC/UVRI-LSHTM Uganda Research Unit, Entebbe, Uganda.
- Center for Global Health and Infection, Brighton and Sussex Medical School, Brighton, United Kingdom.
- Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, USA.
- Clinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Division of Infectious Diseases & International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Lillian Tugume, Fiona V Cresswell, Nicole W Engen, Timothy Mugabi, Enock Kagimu, Nathan C Bahr, David B Meya, David R Boulware
Förderung
- NINDS NIH HHS
- Northern Pacific Global Health
- Wellcome Trust
- Fogarty International Center of the National Institutes of Health
- Wellcome Early Career
- NIAID NIH HHS
- FIC NIH HHS
Zitieren
APA
Tugume, L., Cresswell, F. V., Engen, N. W., Tukundane, A., Kimuda, S., Mugabi, T., Namombwe, S., Kagimu, E., Kabahubya, M., Ellis, J., Bahr, N. C., Meya, D. B., & Boulware, D. R. (2025). Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf261
Vancouver
Tugume L, Cresswell FV, Engen NW, Tukundane A, Kimuda S, Mugabi T, et al. Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf261
BibTeX
@article{Tugume2025,
author = {Tugume, Lillian and Cresswell, Fiona V and Engen, Nicole W and Tukundane, Asmus and Kimuda, Sarah and Mugabi, Timothy and Namombwe, Suzan and Kagimu, Enock and Kabahubya, Mable and Ellis, Jayne and Bahr, Nathan C and Meya, David B and Boulware, David R},
title = {Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf261}
}
EUVIMED